Last updated on November 2017

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery. Clinical trial NCT02542384, CR845-CLIN3001.


Brief description of study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study Evaluating the Analgesic Efficacy and Safety of Intravenous CR845 in Patients Undergoing Abdominal Surgery. Clinical trial NCT02542384, CR845-CLIN3001.

Detailed Study Description

The study schedule is comprised of a 14-day screening period, a treatment period and an observation period. All eligible subjects will be randomized into one of 4 treatment groups (1 of 3 dose levels or matched placebo). Study drug CR845 will be administered intravenously prior to surgery, and at specific time intervals after surgery. Additional rescue pain and anti-nausea medication will be made available. Post surgical changes in pain intensity, nausea and vomiting will be assessed.

Clinical Study Identifier: TX5650

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Cheryl Zinar, RN, BSN

Urologic Consultants of Southeastern Pennsylvania
Bala Cynwyd, PA USA
  Connect »